XML 18 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   126,106,176      
Beginning balance at Dec. 31, 2024 $ 208,730 $ 13 $ 481,679 $ 57 $ (273,019)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   60,433      
Issuance of common stock upon exercise of vested stock options 26   26    
Issuance of common stock under employee stock purchase plan (in shares)   138,513      
Issuance of common stock under employee stock purchase plan 87   87    
Stock-based compensation expense 3,877   3,877    
Other comprehensive income (loss) 20     20  
Net loss (31,646)       (31,646)
Ending balance (in shares) at Jun. 30, 2025   126,305,122      
Ending balance at Jun. 30, 2025 181,094 $ 13 485,669 77 (304,665)
Beginning balance (in shares) at Mar. 31, 2025   126,148,469      
Beginning balance at Mar. 31, 2025 194,435 $ 13 483,865 189 (289,632)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   18,140      
Issuance of common stock upon exercise of vested stock options 8   8    
Issuance of common stock under employee stock purchase plan (in shares)   138,513      
Issuance of common stock under employee stock purchase plan 87   87    
Stock-based compensation expense 1,709   1,709    
Other comprehensive income (loss) (112)     (112)  
Net loss (15,033)       (15,033)
Ending balance (in shares) at Jun. 30, 2025   126,305,122      
Ending balance at Jun. 30, 2025 $ 181,094 $ 13 485,669 77 (304,665)
Beginning balance (in shares) at Dec. 31, 2025 126,469,610 126,469,610      
Beginning balance at Dec. 31, 2025 $ 156,973 $ 13 488,737 243 (332,020)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares) 670,244 670,244      
Issuance of common stock upon exercise of vested stock options $ 1,207   1,207    
Issuance of common stock under employee stock purchase plan (in shares)   84,786      
Issuance of common stock under employee stock purchase plan 142   142    
Stock-based compensation expense 2,530   2,530    
Other comprehensive income (loss) (574)     (574)  
Net loss $ (29,166)       (29,166)
Ending balance (in shares) at Jun. 30, 2026 127,224,640 127,224,640      
Ending balance at Jun. 30, 2026 $ 131,112 $ 13 492,616 (331) (361,186)
Beginning balance (in shares) at Mar. 31, 2026   127,070,480      
Beginning balance at Mar. 31, 2026 144,415 $ 13 491,210 (91) (346,717)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   69,374      
Issuance of common stock upon exercise of vested stock options 102   102    
Issuance of common stock under employee stock purchase plan (in shares)   84,786      
Issuance of common stock under employee stock purchase plan 142   142    
Stock-based compensation expense 1,162   1,162    
Other comprehensive income (loss) (240)     (240)  
Net loss $ (14,469)       (14,469)
Ending balance (in shares) at Jun. 30, 2026 127,224,640 127,224,640      
Ending balance at Jun. 30, 2026 $ 131,112 $ 13 $ 492,616 $ (331) $ (361,186)